Given that the dementia‐associated TRIAD3A variants could not degrade Arc, we sought to investigate whether the mutations in TRIAD3 could affect Arc ubiquitination by performing an in vivo ubiquitination assay (Mabb et al., 2014). The gene discussed is ARC; the disease is dementia.